
@WIRED staff writer on the biotech beat. [email protected] or emullin.06 on Signal
PA
Joined May 2009
- Tweets15.7K
- Following1.1K
- Followers15.1K
- Likes7.6K
Pinned Tweet
Erin had been addicted to meth for years when in January 2025, she received a blast of ultrasound waves to her brain.
She hasn't craved or used drugs since.
I wrote about her journey, and the promise of focused ultrasound for brain disorders, for @WIRED: wired.com/story/brain-focuse…
Emily Mullin retweeted
the texas data center implications are truly insane for the industry. if i was a data center developer i would not feel very good right now
Biotech founder @OcanaSantero told an AI agent to select a gene therapy from a list of 19 and gave it free rein to inject it into a mouse's brain.
Here's how that went: wired.com/story/an-ai-agent-…
Emily Mullin retweeted
New: The FDA has rarely inspected the foreign facilities exporting the vast majority of fresh fruits & vegetables to the U.S., per WaPo investigation.
Only 7.6% of the facilities have been inspected by the agency since 2009.
With @caitlinsgilbert
washingtonpost.com/health/20…
Emily Mullin retweeted
In January 2025 my mom’s lung cancer spread to her brain. The drug with the best chance of helping her was approved in China but not here.
A doctor told me, almost as an aside, that if she were Chinese she could buy it at a pharmacy.
So I flew to Shanghai and came home with 26 boxes in my luggage. That was 19 months ago. My mom is still here, still working, and in her words has had an amazing three years.
The drug was approved in China in 2023. The FDA approved it in July 2025. It still is not for sale here. I know of at least 30 Americans who have made the same trip.
I have been scared to tell this story because I worried it could cost my mom access to the medicine keeping her alive. But the problem matters more than my silence. These drugs need to be developed and available here, and that means FDA reform.
Art Allen at KFF Health News told our story this week. It also ran in The Washington Post.
kffhealthnews.org/health-ind…
The latest AI model for biology is like ChatGPT for DNA—and you can run it locally on a laptop.
wired.com/story/hugging-face…
Emily Mullin retweeted
EXCLUSIVE: Testosterone therapy going even more mainstream as Hims launches its own injectable offerings: wired.com/story/telehealth-g…
Emily Mullin retweeted
"Why would some gene variants perform a valuable service for ancient humans but a disservice now? One answer ... involves infectious disease." nytimes.com/2026/10/20/scien…
OpenAI’s venture arm and Peter Thiel’s Founders Fund are backing Coherence Neuro, a startup developing a brain implant for cancer.
Coherence CEO Ben Woodington says there's "growing synergy" between AI labs and brain-computer interface companies.
wired.com/story/openai-start…
Emily Mullin retweeted
Hats off to @WIRED for this candid journalistic self-examination. The last two paragraphs are a gut punch. RIP Joe Rago, whom I interviewed during the reporting and writing of Bad Blood. apple.news/AwgktUs6RRP2bV0Nj…
It's why 23andMe never turned a profit. Customers rarely returned to their results, and the company never figured out how to use its massive trove of genetic data to develop drugs.
Emily Mullin retweeted
Axios is reporting that the top labs are wargaming scenarios for the aftermath of a catastrophic event in the next 6 - 12 months, that some executives now see as being inevitable.
There is already collaboration between some of the big AI labs and brain-computer interface companies:
OpenAI/Merge Labs
Nvidia/Synchron
Microsoft/INBrain
Not to mention Apple devices now support BCI integration.
There will be more.
Andrew Huberman on why Meta, OpenAI, and Anthropic are all going to become biotech companies.
"Dario came up through neuroscience. Sam, I've spoken to, is extremely smart about the neuroscience, as is Zuck.
The technologists who used to just engineer stuff, they're becoming neuroscientists...and I think most people don't realize that.
They will all tell you, 'Okay, here's the goal. The goal is to be able to read and write from your brain non-invasively.'
Even just for things like drive and motivation, a non-invasive device where you could literally crank up your level of motivation by stimulating the nucleus accumbens and related pathways while engaging in a particular learning task or in hard work, and then turning it off so that you can capture more energy.
That's coming, and those companies are all about that. That's what the real arms race of AI is about."
Emily Mullin retweeted
Exercise and remission from cancer: A randomized trial found 37% improved survival, 28% disease-free survival. But little is being done to incorporate in practice except @UPMC 1st health system covering "exercise oncology" program.
gift link, by @AgrawalNina
nytimes.com/2026/10/06/well/…
EXCLUSIVE: Earlier this year, Sam Altman-backed Merge Labs spun out of the nonprofit Forest Neurotech to pursue ultrasound-based brain-computer interfaces.
Now one of Forest's other cofounders has launched a rival. My story for @WIRED: wired.com/story/bridge-neuro…
The resurgence of measles in the US is forcing hospitals and health systems to adopt new protocols and procedures to deal with a disease they haven't seen in decades. My latest for @WIRED: wired.com/story/measles-is-f…
Emily Mullin retweeted
SCOOP: Top researchers at Columbia, Stanford, and others thought they were elected to elite scientific societies alongside Nobel laureates. The catch? The organizations are a sham.
I spent the last month investigating a massive academic scam, for @Nature
nature.com/articles/d41586-0…
Emily Mullin retweeted
Hello from the MAHA Summit.
A number of reporters denied credentials despite empty press seats.
A security guard first said he needed to escort me everywhere but now has given up I guess.
Emily Mullin retweeted
people have said it before but the whole shortform video / youtube / podcast content industry is so extractive of actual newsroom labor, and as far as I can tell very few of those studios have hard news operations, reporters / checkers / researchers...
Emily Mullin retweeted
I've been covering prediction markets intensively for just over six months now and felt like it was the right time to unleash this take... to understand them, you need to understand that they are a type of media company: wired.com/story/prediction-m…

















